Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Spotlighting the gender gap in pharma research
The European Medicines Agency (EMA) is launching initiatives to better embed women's health considerations in medicines development and regulation. Women live longer than men on average but spend more of their lives in poorer health. This disparity…
Stock Market Today Live, July 13: Stock to buy today: Piramal Pharma
Sensex Today, Nifty 50 | Stock Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 13th July 2026. Published on July 13, 2026 01:08…
New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
Pharmacodynamic effects in the human brain and energy metabolism biomarker data presented at AAIC support further clinical development of VNA-318 in Alzheimer's disease LAUSANNE, Switzerland, July 13, 2026 – Vandria, a clinical-stage biotech…
Short Interest in Astellas Pharma Inc. (OTCMKTS:ALPMY) Increases By 201.3%
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) was the target of a significant increase in short interest during the month of June. As of June 30th, there was short interest totaling 49,919 shares, an increase of 201.3% from the June 15th…
Ascendis Pharma A/S (NASDAQ:ASND) Given Consensus Rating of 'Buy' by Analysts
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) has earned a consensus recommendation of 'Buy' from the nineteen research firms that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Given Consensus Recommendation of 'Hold' by Analysts
Shares of Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) have been given a consensus rating of 'Hold' by the nine analysts that are covering the firm, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold…
Architecting MedReach AI: Solving Data Rot and Regulatory Bottlenecks in Pharma Marketing
As we kick off Month 1 of our AI Software Development Capstone, I am thrilled to officially introduce the project I will be co-developing over the next five months: MedReach AI. In my role as the Project/Scrum Master and Backend Architect, I am…
Watch The $360 Billion Market that Medicine Got Wrong for 20 Years
The $360 billion dollar women's health market is made of several categories that are often overlooked – one of which is menopause. The condition has gone largely unnoticed by pharma and biotech firms, employers, and investors, despite…
Santhera Expands Biomedica Agreement to Extend AGAMREE (Vamorolone) Distribution Across Central Asia and the Caucasus
Pratteln, Switzerland, July 13, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces an expansion of its exclusive distribution agreement with Biomedica for AGAMREE (vamorolone), extending the partnership to include Georgia…
Here are the 3 big things we're watching in the stock market this week
The common thread linking this week's biggest market events is the state of the U.S. economy. The biggest day is Tuesday, when the nation's largest banks — JPMorgan, Bank of America and Citigroup, along with Club names Wells Fargo and…
BridgeBio: 'Strong Buy' Attruby Differentiation And Several NDA Submissions In Play (NASDAQ:BBIO)
BridgeBio Pharma (BBIO) remains a 'Strong Buy,' driven by regulatory approvals, robust pipeline progress, and significant commercial momentum for Attruby in ATTR-CM. Company has achieved U.S. and international approvals for acoramidis, with Q1 2026…
UroGen's Chief Medical Officer Sold $400,000 in Stock After a 191% Run
Mark Schoenberg, Chief Medical Officer, sold 10,000 ordinary shares of UroGen Pharma Ltd. (URGN 4.15%) on July 9, 2026, for a total value of $400,000, according to an SEC Form 4 filing. MetricValueTransaction value$400,000Shares…
Quit whining, AOC: Gen Z should THANK Boomers for what they're leaving behind
Alexandria Ocasio-Cortez says she knows why socialism is on the rise: Blame it on the Boomers. “Millennials and Gen Z combined, now for the first time, are eclipsing the number of Baby Boomers,” she explained recently. “Young…
25 Year Old's Big Dream: Manufacturing In Space
'ISRO is planning to build a Bharatiya Antariksh Station by 2030. So, our goal is to create a vehicle that can supply modules to the Bharatiya Antariksh Station and bring the products back.' There is not a child who has not dreamt of becoming an…
Candriam S.C.A. Makes New Investment in Teva Pharmaceutical Industries Ltd. $TEVA
Candriam S.C.A. bought a new stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund bought 467,562 shares of the company's stock…
Receive a Daily briefing on Pharma Industry News
Get Started